(Q35840388)

English

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

scientific article published in February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

George Dranitsaris

6

object named as

G Dranitsaris

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

J A Maroun

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

L B Anthony

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

N Blais

3

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

R Burkes

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

S D Dowden

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

B Samson

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

A Shah

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

M P Thirlwell

9

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

M D Vincent

10

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

R Wong

11

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

1 February 2007

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Current Oncology

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

13-20

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

copyright license

Creative Commons Attribution 4.0 International

1 February 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Recommended guidelines for the treatment of cancer treatment-induced diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Management of cancer treatment-related diarrhea. Issues and therapeutic strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Recommended guidelines for the treatment of chemotherapy-induced diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

11 July 2018

Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

24 September 2018

Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

24 September 2018

Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

24 September 2018

The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

24 September 2018

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1891194

24 September 2018

Octreotide Acetate in the Treatment of Fluorouracil-Induced Diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 8: Clinical investigation. Use of a flexible dosage schedule in a double-blind comparison of loperamide with diphenoxylate in 614 patients suffering from acute diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double blind crossover comparison of loperamide with diphenoxylate in the symptomatic treatment of chronic diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loperamide in the symptomatic control of chronic diarrhoea. Double-blind placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/17576459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3747/CO.2007.96

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35840388&oldid=1871741128"